2016 Opioid Prescribing Guideline
This page is archived for historical purposes and is no longer being maintained or updated.
Please see Process for Updating the Opioid Prescribing Guideline for the most up-to-date information.
The Opioid Guideline Workgroup – 2016 was charged with:
- Reviewing the quality of the clinical and contextual evidence reviews.
- Reviewing each of the recommendation statements and accompanying rationale
- Considering for each recommendation:
- The quality of the evidence supporting the recommendation (the accuracy of the evidence quality rating; i.e., evidence “type”);
- The balance of benefits and risks associated with the recommendation (the degree to which the benefit of issuing the recommendation outweighs the harms);
- The values and preferences of providers and patients related to the recommendation (the degree to which there is variability or uncertainty in values and preferences);
- The cost feasibility of the recommendation (the degree to which implementation is feasible for health systems and patients financially); and
- The category designation of the recommendation (whether category A or category B is justified). Category A recommendations apply to all patients; Category B recommendations require individual decision making where different choices will be appropriate for different patients so that providers must help patients arrive at a decision consistent with patient values and preferences and specific clinical situations.
- Workgroup members will be provided with the Proposed 2016 Guideline for Prescribing for Opioids for Chronic Pain and other supporting materials to assist with items #1-3.
- Provide a summary of the workgroup’s observations associated with items #1-3 above of the Proposed 2016 Guideline for Prescribing Opioids for Chronic Pain, including points of agreement and disagreement.
Christina A. Porucznik, Ph.D., M.S.P.H.
Department of Family and Preventive Medicine
University of Utah
Designated Federal Official
Amy B. Peeples, M.P.A.
National Center for Injury Prevention and Control
Centers for Disease Control and Prevention
Anne Burns, R.Ph.
Vice President, Professional Affairs
American Pharmacists Association
American Chronic Pain Association
Traci Green, Ph.D.
Boston Medical Center Injury Prevention Center
Boston School of Medicine
Associate Professor of Emergency Medicine
The Warren Alpert School of Medicine of Brown University
Rhode Island Hospital
Mitchell Katz, M.D.
Los Angeles County Health
Erin Krebs, M.D., M.P.H.
Associate Professor of Medicine
Women’s Health Medical Director
Minneapolis VA Health Care System
University of Minnesota
Chinazo Cunningham, M.D., M.S.
Division of General Internal Medicine
Albert Einstein College of Medicine
Montefiore Medical Center
Katherine Galluzzi, D.O., C.M.D.,F.A.C.O.F.P.
Professor and Chair
Department of Geriatrics
Director, Comprehensive Care at
Philadelphia College of Osteopathic Medicine
Gregory Terman, M.D., Ph.D.
Department of Anesthesiology and Pain Medicine
and the Graduate Program in Neurobiology Behavior
University of Washington
Mark Wallace, M.D.
Professor of Clinical Anesthesiology
Chair Division of Pain Medicine
University of California, San Diego Medical Center